Goulding K R, Peyton P J, Story D A, Parker A, Leslie K
Manager, Australian and New Zealand College of Anaesthetists Clinical Trials Network, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria.
Deputy Chair, Australian and New Zealand College of Anaesthetists Clinical Trials Network Executive, Honorary Fellow, Department of Surgery, University of Melbourne, Head of Research, Department of Anaesthesia, Austin Hospital, Melbourne, Victoria.
Anaesth Intensive Care. 2017 Mar;45(2):196-201. doi: 10.1177/0310057X1704500209.
The Australian and New Zealand College of Anaesthetists (ANZCA) has more than 200 accredited training sites in Australia, New Zealand, Hong Kong, Malaysia and Singapore, many of which participate in ANZCA Clinical Trials Network (CTN)-endorsed clinical trials. We undertook a survey of accredited sites to determine research capability, activity and potential. With ethics committee approval an electronic survey was distributed to accredited sites in July 2015. Of 207 accredited sites, 167 were sent the questionnaire (after eliminating ineligible sites) and 128 responded. Response rates for Australia, New Zealand, Hong Kong, Malaysia and Singapore were 100%, 100%, 35%, 25% and 75% respectively. Forty-four (34%) of 128 responding sites had a head of research; 101 (80%) of 126 responding sites were active in research; 42 (33%) of 126 responding sites had no publications since January 2011 and 15 (12%) had >50 publications; 95 (76%) of 125 responding sites had at least one specialist anaesthetist engaged in research (median = 4 [range 1-25]); and 45 (36%) of 125 responding sites had at least one research coordinator (median = 2 [range 1-15]). Fifty-eight (28%) of the 207 accredited sites were identified as participating in recent ANZCA CTN-endorsed clinical trials. Research capability and activity were higher in these sites. This survey has identified a strong base upon which to expand clinical trial activity, and regions, sectors, investigators and research coordinators who may benefit from additional support.
澳大利亚和新西兰麻醉师学院（ANZCA）在澳大利亚、新西兰、中国香港、马来西亚和新加坡拥有200多个经认可的培训地点，其中许多参与了ANZCA临床试验网络（CTN）认可的临床试验。我们对经认可的地点进行了一项调查，以确定其研究能力、活动和潜力。经伦理委员会批准，2015年7月向经认可的地点发放了电子调查问卷。在207个经认可的地点中，167个被发送了问卷（剔除不合格地点后），128个做出了回应。澳大利亚、新西兰、中国香港、马来西亚和新加坡的回应率分别为100%、100%、35%、25%和75%。128个做出回应的地点中有44个（34%）有研究负责人；126个做出回应的地点中有101个（80%）积极开展研究；126个做出回应的地点中有42个（33%）自2011年1月以来没有发表过论文，15个（12%）发表的论文超过50篇；125个做出回应的地点中有95个（76%）至少有一名专科麻醉师从事研究（中位数为4[范围1 - 25]）；125个做出回应的地点中有45个（36%）至少有一名研究协调员（中位数为2[范围1 - 15]）。207个经认可的地点中有58个（28%）被确定参与了近期ANZCA CTN认可的临床试验。这些地点的研究能力和活动较高。这项调查确定了一个强大的基础，在此基础上可以扩大临床试验活动，并确定了可能从额外支持中受益的地区、部门、研究人员和研究协调员。
